ACT 2023 Annual Meeting

Orlando, Florida , United States

→ Booth #333 Spotlight on difficult-to-test samples and in vitro quantitative potency assessment as an alternative to the Local Lymph Node Assay Come meet us at booth #333 and join our poster presentation to learn how the GARD assays are used to fill data gaps for skin sensitizing hazard and quantitative potency assessment, providing a high […]

Annual Medical Device Biocompatibility Conference

Berlin, Germany

Presentation The GARD®skin Medical Device assay for assessing the skin sensitizing potential of medical devices: A case study on the use of in vitro data in the biological evaluation for CE marking according to MDR Key Points A proof-of-concept study using the GARD®skin Medical Device assay to evaluate the skin sensitizing potential of medical device […]

Webinar: Safety of acrylate monomers, metals, and other materials used in medical device development

Join our upcoming free webinar to explore the effective utilization of in vitro methods for safety assessment of materials during product development of Medical Devices. We will discuss recent advancements in in vitro methods for assessing the endpoints of skin irritation and skin sensitization. Learn how to integrate these assessments into your product development process […]

Webinar: Spotlight on Difficult-to-Test samples

Join our upcoming webinar to explore the recent advancement in GARD® for Skin Sensitization assessment, with a specific focus on substances that fall outside the applicability domains of the conventional in vitro assays in the OECD Test Guidelines. Our skin sensitization experts will address challenges posed by various Difficult-to-Test substances, discussing the applicability domain of […]

2024 SOT Annual Meeting & ToxExpo

Booth #732 Discuss your testing needs with us   Exhibitor-Hosted Session Expert round table on NAMs and industry trends Tuesday, 12 Mar | 9:00 am-10:00 am Posters Spotlight on PoD, NESILs, product development and CE-marking of Medical Devices Monday, 11 Mar | 9:15 am-11:15 am 🎫 Joint poster with Sonova P487 #3362 | Unveiling skin sensitizing potential: case studies […]

Webinar: Advancing NAMs for Skin Sensitization Testing

Spotlight on Applicability Domain, Quantitative Potency Assessment and Medical Devices In case you missed SenzaGen’s poster presentations and scientific session at this year’s SOT, we are pleased to offer you a new opportunity to participate on April 23, 2024! In this webinar Dr Andy Forreryd, SenzaGen's in vitro toxicology expert, will summarize the latest GARD data from industry collaborations: […]

Cosmetotest

ENS Lyon, France

Program 'Introduction to GARDskin (OECD TG 442E) for evaluation of skin sensitization hazard with dose-response option for quantitative risk assessment' Date: 30/05 Session 1: Safety: from irritation to sensitization Presenter: Andy Forreryd, SenzaGen Booth: #21

ESTIV Congress 2024

Come meet us at booth #22 and join our presentations to hear the latest news about GARD® and how the assays are used to fill data gaps for skin sensitizing hazard and quantitative potency assessment. Additionally, meet ToxHub, a SenzaGen Group company, and benefit from expert toxicology and regulatory advice. Presentations and Posters Our team […]